Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 75 results for "cbm iv"

Essar Targets CBM In Eastern India

The company plans includes drilling 650 development wells in the Raniganj East Block. Essar Oil Ltd. is focusing on exploration and development of coalbed methane (CBM) assets in eastern India. The company has lined up a plan to drill 650 ... E&P Magazine, 1 month ago

EQT : Reports Third Quarter 2014 Earnings

Operational Results Continue to Improve GP Achieves Maximum Distribution Threshold EQT Corporation (NYSE:EQT) today announced third quarter 2014 net income attributable to EQT of $98.6 million, or $0.65 per diluted share ...
 4 Traders1 week ago EQT Reports Third Quarter 2014 Earnings  TheStreet.com6 days ago

Niko to look into new Indian gov't gas pricing policy

NIKO ANNOUNCES GOVERNMENT OF INDIA'S REVISION OF DOMESTIC GAS PRICES Niko Resources Ltd. has provided an update. On Oct. 18, 2014, the cabinet committee of economic affairs of the government of India approved the new domestic gas pricing policy ...
 Stockwatch1 week ago Niko Announces Government of India's Revision of Domestic Gas Prices  Wall Street Business Network1 week ago

Cabinet approves new domestic gas pricing policy

The Cabinet Committee of Economic Affairs, chaired by the Prime Minister Shri Narendra Modi, today approved the new domestic gas pricing policy. The salient features of the new Gas Pricing Policy are follows: As per the formulation approved by ...
 India Infoline1 week ago India Govt Cabinet Committee approves new domestic Gas pricing policy  CommodityOnline1 week ago Ministry of Petroleum and Natural Gas of Repub : Revision of Domestic Gas Prices  4 Traders1 week ago Revision of Domestic Gas Prices  Noodls1 week ago

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an ...
 Zacks.com3 weeks ago CorMedix Files IND Application for Neutrolin in the US  Yahoo! Finance1 month ago

Myanmar: 2014 Article IV Consultation-Staff Report; Press Release; and Statement by the Executive Director for Myanmar

Published: October 6, 2014 Electronic Access: (PDF file size is 1,519KB) Use the free to view this PDF file. Summary: KEY ISSUES Context: The authorities continue to make progress on their far-reaching political and economic reform program. Key ...
 IMF3 weeks ago Press Release: IMF Executive Board Concludes 2014 Article IV Consultation with Myanmar  IMF3 weeks ago IMF Executive Board Concludes 2014 Article IV Consultation with Myanmar  Newswit.com3 weeks ago

Genome Features of the Endophytic Actinobacterium Micromonospora lupini Strain Lupac 08: On the Process of Adaptation to an Endophytic Life Style?

Background For a long time, it was considered that a healthy plant was a plant without microbes within its tissues. However, this view has started to change with new approaches to allow strains to grow for a longer time upon isolation as well as ...
 Plosone.org4 weeks ago

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301

Celldex Therapeutics, Inc. ( CLDX ) announced the commencement of a pilot study on CDX-301, a potent hematopoietic cytokine, for the mobilization and transplantation of allogeneic hematopoietic stem cells in patients with hematological malignancies ...
 Yahoo! Finance1 month ago

Softwood lumber prices in Austria stable in August

Softwood lumber prices in Austria were stable in August, with the levels of July mostly maintained . Edged boards and squared timber have softened slightly. The upper price limit for rough boards is EUR 1/m3 lower than July, while width boards are ...
 Fordaq1 month ago Slight price increase for softwood lumber in Austria  Fordaq2 months ago

Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA

Halozyme Therapeutics, Inc. ( HALO ) announced that the FDA has lifted the clinical hold from a phase Ib/II study (Study S1313). The study is evaluating PEGPH20 (PEGylated recombinant human hyaluronidase) in combination with a modified FOLFIRINOX ...
 Yahoo! Finance1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less